Newsroom

Sorted by: Latest

-

Portal Biotechnologies Accelerates Growth with Latest Round Led by NFX, Expanded DARPA Contract, and Broad Adoption Across Top Pharma and Academic Centers

WATERTOWN, Mass.--(BUSINESS WIRE)--Today, Portal Biotechnologies, Inc. (“Portal”), a cell engineering and drug discovery platform company, announced updates on significant commercial progress and the closing of an oversubscribed $9M financing round led by NFX and participation from existing investors including IA Ventures, Pear VC, Undeterred Ventures, IKJ Capital, and TechU Ventures. Portal is building the universal infrastructure for cell engineering across drug discovery and cell therapy. Th...
-

Arrowhead Pharmaceuticals to Host a Webinar on its Cardiometabolic Pipeline as Part I of the 2026 Summer Series of R&D Webinars

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced its plan to host a 2026 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference (RNAi) based medicines that utilize the company’s proprietary Targeted RNAi Molecule (TRiM™) platform. Each webinar in the Summer Series will focus on a specific therapeutic area and will feature presentations by Arrowhead team members about the company’s clinical candidates and externa...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 17.06.2026 LANDXEN.LN IE000C75IMX8   15,878.00 USD    313,516.03   19.745  ...
-

Carte Financial Group Names Continuum the Exclusive AI Client Intelligence System for Its National Advisor Network

TORONTO--(BUSINESS WIRE)--Carte Financial Group, the Ontario-based financial services organization, today named Continuum the exclusive AI client intelligence system for its national network of over 1000 independent advisors. The agreement brings Continuum to financial advisors at Carte Wealth Management Inc. and extends to its insurance professionals through Carte Risk Management Inc., one of Canada's fastest-growing MGAs. Carte was founded in 2007 on a planning-first model, in which financial...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 17.06.2026 LANDXN.LN IE000RN036E0   34,035.00 USD    736,640.16   21.644  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Innovative Transaction & Process UCITS ETF 17.06.2026 LEGR LN IE00BF5DXP42  950,002.00 USD  51,493,071.79   54.203  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NASDAQ Clean Edge Green Energy UCITS ETF 17.06.2026 QCLN.LN IE00BDBRT036 2,250,002.00 USD  52,946,104.03   23.532  ...
-

AIRO Debuts RQ-70 Long-Range ISR Drone Platform at Eurosatory 2026, Advancing Multi-Product Growth Strategy

MCLEAN, Va.--(BUSINESS WIRE)--AIRO Group Holdings, Inc. (Nasdaq: AIRO), a next-generation aerospace and defense company, in combination with Sky-Watch A/S, its wholly owned subsidiary, today announced the public unveiling of its RQ-70, a new deep-reach intelligence, surveillance and reconnaissance (ISR) drone, extending ISR capabilities beyond the immediate tactical frontline. The announcement was made at Eurosatory 2026, a global event for defense and security held in Paris. AIRO expects the R...
-

CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant patients and caregivers, today announced its participation at the American Transplant Congress (ATC) 2026, taking place June 20–24 in Boston, Massachusetts. Real-world clinical use and scientific advancements involving AlloSure® Kidne...
-

Oklo, Centrus Sign Letter of Intent to Purchase Nuclear Fuel for Aurora Powerhouse Deployment in Southern Ohio

PIKE COUNTY, Ohio--(BUSINESS WIRE)--Oklo Inc. (NYSE: OKLO) (“Oklo”), an advanced nuclear technology company, and Centrus Energy Corp. (NYSE: LEU) (“Centrus”), a uranium enrichment and nuclear fuel services provider, announced today a Letter of Intent under which Centrus agrees to supply enough domestic high-assay low-enriched uranium (HALEU) to power up to five Aurora powerhouses for multiple years, with deliveries to Oklo scheduled to begin in 2029. Centrus will supply HALEU from its American...